The -174/ - 597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis

Journal of the Neurological Sciences

Volumn 190, Issue 1-2, 2001, Pages 69-72

  Fedetz, Mariá ^a   Matesanz, Fuencisla ^a   Pascual, María ^a   Martín, Javier ^a   Fernández, Oscar ^b   Guerrero, Miguel ^c   Alcina, Antonio ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Cytokine; Gene polymorphism; Immunopathology; Interleukin 6; Multiple sclerosis; SNP

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CHROMOSOME MAP; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 0035885733     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00595-0     Document Type: Article

References (25)

1. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998;9:259-75.
2. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997; 15:307-39.
3. Maimone D, Guazzi GC, Annunziata P. IL-6 detection in multiple sclerosis brain. J Neurol Sci 1997;146:59-65.
4. Navikas V, Matusevicius D, Soderstrom M, Fredrikson S, Kivisakk P, Ljungdahl A, et al. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996;64:63-9.
5. Huang YM, Xiao BG, Ozenci V, Kouwenhoven M, Teleshova N, Fredrikson S, et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J Neuroimmunol 1999;99:82-90.
6. Hautecoeur P, Forzy G, Gallois P, Demirbilek V, Feugas O. Variations of IL2, IL6, TNF alpha plasmatic levels in relapsing remitting multiple sclerosis. Acta Neurol Belg 1997;97:240-3.
7. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, Steffensen S, et al. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 1997;2(2):125-9.
8. Okuda Y, Sakoda S, Saeki Y, Kishimoto T, Yanagihara T. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J Neuroimmunol 2000;105:120-3.
9. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
10. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
12. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998;51:605-12.
13. Faulds G., Fishman D., Woo P., Humphries S., Genbank Accession number AF 048692, 1998.
14. Olomolaiye O, Wood NA, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998;25:267.
15. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
16. Osiri M, McNicholl J, Moreland LW, Bridges SL. A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans. Genes Immun 1999;1:166-7.
17. Pascual M, Nieto A, Matarán L, Balsa A, Pascual-Salcedo D, Martín J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000;1:338-40.
18. Ausubel FAR, Brent RE, Kingston DD, Moore JG, Seidman JA, Smith JA, et al. Current protocols in molecular biology. New York: Wiley-Interscience, 1990.
19. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf JA, et al. An IL-6 promoter polymorphism is associated with a lifetime risk of development of kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000;96:2562-7.
20. Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000;20:885-8.
21. Vanderbroeck K, Fiten P, Ronsse I, Goris A, Porru I, Melis C, et al. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes Immun 2000;1:460-3.
22. Schmidt S, Papassotiropoulos A, Bagli M, Harzheim M, Heun R, Klockgether T. No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′ flanking region of the interleukin-6 gene in patients with multiple sclerosis. Neurosci Lett 2000;294:139-42.
23. Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 1999;45:666-8.
24. Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, et al. Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000;283:109-12.
25. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation. J Biol Chem 2000;275:18138-44.